Neumonía intersticial inducida por bloqueo androgénico máximo como tratamiento de cáncer de próstata avanzado: Report of one case
Maximum androgen blockade is the standard endocrine treatment for advanced prostate cancer. Interstitial lung disease in different degrees of severity, with low mortality and excellent response to treatment may appear with its use. We report a 77 years old patient with advanced prostate cancer who d...
        Enregistré dans:
      
    
                  | Auteurs principaux: | Molina Mancero,Guillermo, Picón,Xavier, Di Tullio,Fernando, Ernst,Glenda, Dezanzo,Pablo, Salvado,Alejandro, Chertcoff,Julio F | 
|---|---|
| Langue: | Spanish / Castilian | 
| Publié: | 
        
      Sociedad Médica de Santiago    
    
      2016
     | 
| Sujets: | |
| Accès en ligne: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016001000017 | 
| Tags: | 
       Ajouter un tag    
     
      Pas de tags, Soyez le premier à ajouter un tag!
   
 | 
Documents similaires
- 
                
        
          Interstitial lung abnormalities – current knowledge and future directions        
                  
par: Gisli Thor Axelsson, et autres
Publié: (2021) - 
                
        
          Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias        
                  
par: Tomoyuki Fujisawa, et autres
Publié: (2021) - 
                
        
          Enfermedades pulmonares intersticiales. Una perspectiva actual        
                  
par: SALINAS,MAURICIO, et autres
Publié: (2019) - 
                
        
          High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial        
                  
par: Leona M. Dowman, et autres
Publié: (2021) - 
                
        
          Clinical Case of Idiopathic Interstitial Pneumonia: Expert Approaches        
                  
par: V. M. Karetnikova, et autres
Publié: (2019)